Items
Subject is exactly
Healthcare
-
05/12/2020
Kasie Meyers Oral History, 2020/05/12
Interview with Kasie Meyers by Jack Halls. In this interview, Kasie Meyers discusses how COVID has impacted her role as a nurse and the changes she and her colleagues face. She also discusses her journey as a student and how covid has impacted her studies, she touches on her role as a mother and the difficulties that have been heightened because of the pandemic. She expresses how her relationships with friends and family have changed and also discusses her view on the government and its handling of the pandemic. -
05/21/2020
Rodrigo Hernández Montero Oral History, 2020/05/21
En esta entrevista Rodrigro Hernandez Montero es entrevistado por Carmen Kordick Coury concerniente al covid-19 en Costa Rica. Rodrigo trabaja en odontología tiene 40 años y vive en Heredia. Trabaja en un hospital donde empezó a escuchar del virus por primera vez. Habla sobre el cambio que ocurrió en su trabajo y del protocoló de la cirugía oral. Describe los cambios de su rutina diario, reacciones de sus pacientes y el cambio de protección que empezó a usar, como la máscara N95. Rodrigo habla de cambios de la economía y como la pandemia afecto el negocio de su papá. Habla sobre su familia y las preacauciones que ha tomado al llegar del trabajo para proteger a sus ser queridos. Rodrigo habla del cambio del dinámico familiar y los sentimientos de aislado que siente en no poder ver a su familia y sus amigos. Habla de los fuentes principales de información donde el se mantiene informado. Para terminar, Rodrigo habla del gobierno, de la xenofobia y el miedo que existe en Costa Rica. -
09/24/2020
Christina Lefebvre and Lynne Goltra Oral History, 2020/09/24
An interview with a Massachusetts General Hospital OBGYN detailing the struggles of COVID and how the medical community has responded to the pandemic. -
11/10/2020
Kenneth and Wendy Moran Oral History, 2020/11/10
C19OH -
2020-11-11
Cassie Nyhus Oral History, 2020/11/11
Cassie Nyhus was born and raised in Hayward, Wisconsin. She now lives in Bloomer, Wisconsin and works in Rice Lake, Wisconsin in the Radiology department. In this interview Cassie dives deep into what it’s like to work in the healthcare field during a pandemic and her experiences firsthand with the people she has seen and the way these events have changed her workplace. She also touches on her thoughts on people’s rights during this pandemic, and talks heavily about her own personal situation of the stresses that come with being pregnant and soon to be a mother during a global pandemic. -
05/07/2021
Chris Delvin Oral History, 2021/05/07
Chris Delvin is the RN perioperative manager at the Marshfield Clinic in Eau Claire. In this interview, Chris discusses the effects of the pandemic on his clinic and how he and his staff responded by converting a surgical clinic into a negative flow covid unit and doubling the number of beds they could handle. He talks not only about work but also about how the pandemic has transformed his home and spiritual life. Matt Schneider also joins midway through and offers his perspectives on how Chris managed the situation and contributed to helping protect his community. -
12/08/2020
Jackie Weber Oral History, 2020/12/08
Jackie Weber was born in West Bend, Wisconsin. She now lives in Milwaukee, Wisconsin and works as an occupational therapist in one of the major Milwaukee hospital systems. In this interview she dives deep into the affect that Covid-19 has had on her workplace such as staffing issues, equipment shortages, and burnout. She also talks about the emotional weight of working in such a stressful situation and not being able to help people in the same ways as pre-pandemic. She also speaks on the ways in which hospitals are changing how they treat Covid and often cites an ever-changing set of policies. Throughout the interview she intertwines her views on policy proposals, and anti-maskers into her strong points about safety. -
04/22/2021
Lou Ann Koval Oral History, 2021/04/22
Lou Ann Koval was born in East Lansing Michigan, and currently works for a company called Laird Connectivity. This company makes electronics, some of which were made to help keep people safe from COVID. During the pandemic, she switched between two companies and shared some of the struggles of joining a new company without anyone being able to have a real social interaction with her. She also talks about the struggles of balancing a social life and keeping involved with her elderly family members. She also briefly talks about her opinion on the political actions taken to avoid COVID and some of her responses to stay healthy during this pandemic. -
12/08/2020
Deshawn Lee Oral History, 2020/12/08
The novel coronavirus known as COVID-19, was first officially reported on December 31, 2019, by Chinese officials in Wuhan, China. Since then, the lives of people around the world have been dramatically transformed as the world’s population fights one of the deadliest and most contagious pandemics of modern history. Archivists of all different backgrounds quickly began engaging in what is known as rapid-response collecting—the archiving of historically important, donated artifacts and the collection of oral accounts from volunteer witnesses. Milwaukee resident Deshawn Lee was willing to sit down with Westley Hart, a student at UW-Eau Claire, and participate in the university’s effort, in collaboration with the Journal of the Plague Year Archive as well as the Chippewa Valley COVID-19 Archive Project, to engage in rapid-response collecting of oral histories from the Upper Midwest region. Deshawn comes in direct contact with the virus every day as he works, transporting patients from place to place at Froedtert Hospital and Medical College. He is also a hard-working student, pursuing a career in counseling while raising his 1-year-old daughter together with his girlfriend on the south side of Milwaukee. The purpose of this interview is to document the dynamic impacts that the coronavirus pandemic has had on Americans in the year 2020, particularly those of the Upper Midwest. His account touches on his personal interactions with the virus in work, school, and public, the actions that his local government has taken in response to the virus, as well as the virus’s interaction with the nationwide public protests that followed a series of high-profile police brutality tragedies, with an interest on the impact felt by his local Milwaukee community. -
2021-12-01
Graduate Clinicians and Teletherapy
I am currently a senior majoring in communication sciences and disorders. Last year, student clinicians provided services entirely online through teletherapy. For clinicians, the transition to online was very difficult. It required relearning how to implement services that were just as engaging and effective as in-person therapy. For clients, some struggled immensely. Furthermore, sometimes the clients had trouble staying focused and supports could not be implemented the same way they normally would be in person. Some clients excelled online and have chosen to continue teletherapy even after in-person therapy was offered. For the future, I think SLPs and student clinicians will have to view the way they provide therapy differently. It is now expected that any clinician can successfully provide therapy in multiple different modes. -
2021-12-10
My Time During Covid-19
During the Covid-19, I experienced a stressful time period just like most people. When the lockdown first happened I was scared and uncertain of what would happen. It was the first time in my life that I have ever had the feeling of being unable to hang out with friends and see family members. Many people I knew were still hanging out with people and doing social activities just like there was not a pandemic going on. I wanted to still do social activities with them and visit people but I was unsure if that was safe to do, so I decided to just stay in the house and be safe. My grandma is going through chemotherapy and I did not want her to catch covid if I did happen to get it, so my whole family was being extra careful to not catch the virus. During this time period I kept in touch with friends by playing online video games and facetiming my family members. The strangest part of this time period for me was the social aspect of the pandemic. Whenever you would go to the store in my area the shelves would be empty, and people would just walk past you and were not willing to talk to anyone. I usually take in person classes for school, and I had to make the transition to doing classes online for the first time. All sports had to cancel all of their events so I was not able to compete in any of the events for the entire year. This was definitely a year of fear and uncertainty for many people, but when I look back there were a lot of positives that happened. The most positive thing was that I got to spend a lot of time with my family. Mostly everyone in my household is busy all the time and we all never get too much time to just sit and talk even though we all live in the same house. During the lockdown we all got the chance to spend a lot of time together since there was not a whole lot going on. I was also able to spend a lot of time talking with friends that I have not talked to in a long time over online video games, and I got back into skateboarding which is a hobby that I have not done in seven years. Even though I was fearful of the virus, I experienced a time period where I could focus a lot on being as productive as possible, and it gave me a lot of gratitude for how things are today where things are mostly back to normal. Just like it was for a lot of people, there were definitely a lot of bad experiences that happened during the Covid -19 period for me, but there are also good things that I am thankful for. Hopefully people can focus on the positives that happened during that time period as we push forward past it. -
2020-04-29
Giving Birth During The Pandemic
My name is Niki, I'm 38 and live in Clovis CA. In March of 2020, I was about 8 and a half months pregnant with my son, Tate. I went to school part time, majoring in Early Childhood Development. I was also a stay at home Mom to my then 3 year old daughter, Quinn. She’s my driving force in school because she is on the autism spectrum. In March she was just beginning to talk and have real words,and her brother was coming, it was an exciting time. My husband Mike, is what they call an over the road trucker. Meaning he was gone all week and home for 30 hours over the weekend. The situation was not ideal for us, but it worked to give me the freedom to be with Quinn to take her to the therapies she needed. Then Covid came to the US. Everyone was forced inside. School shut down. The daycare closed. All therapies were put on hold. Everyone was told to wear a mask and sanitize everything. My baby shower was canceled too many people, myself included, were too scared to get together. Mike was not allowed to come home, in fear of being exposed or exposing us. He had to stay on the truck and keep delivering supplies. Then the hospital called and said I needed to prepare that the beds might fill up in the maternity wards with Covid cases and I might need to do a home birth. Could I find someone to assist me ? I had no one! We had only lived here for a year and I haven't made many friends. I had my Mom but she’s older, not able to deliver a baby and quarantined for her health. My sister lived kinda close but she was with her family and was quarantined like everyone else.I had my three-year-old who only had 4 real words !! Then the hospitals call and say “ Don’t worry you can give birth here, no one can be with you and we might take your baby from you right away and keep them from you for about two weeks to make sure they dont have Covid '' Um No ! Home birth sounds good right about now. I had the worst dreams up until my son’s birth. Thankfully, there were beds open in the maternity ward. Thankfully my husband's dispatch got him home just in time for Tate’s arrival. The hospitals allowed one support person in the room for the birth, so he was there. It was the scariest experience. I begged everyone to not take my baby. The hospital didn’t look like a hospital. Everything was covered in white plastic from ceiling to floors. Everyone had on masks and face coverings. It was a scene from a scifi movie.It was one of the scariest times of my life. Amidst all the chaos and stress my beautiful chunky completely healthy son made his entrance into this world on April 29th, 2020. We stayed in the hospital for two days and no one took him from me. I made sure of that. We went home and adjusted to life with a newborn and living with Covid like everyone else. Its been a year and a half and the hospitals have not changed the rules about only allowing one support person in the delivery room. I try to share as much information to expecting mothers as I can. There are no in and out privileges anymore.Once you are in the hospital, you have to stay there. You need to pack snacks! Or you can have food delivered to the hospital. Still can't have visitors. Have an extensive “go bag” ready for when it’s time to go. I hope with all the advances with the vaccine and lowering cases and people being more conscious of their health the hospitals will relax a little on the support team numbers for expecting moms soon. That’s my Covid19 share. -
2021-12-09
Lana Elzein Oral History, 2021/12/09
This story is an update to our first post where we talk about how learning about previous pandemics in our college course History of Global Pandemics has provided insight and consoled us as we experience the current Covid-19 pandemic. -
2021-12-08
End of Semester Covid-19 Interview Oral History 2021/12/08
This interview is about our thoughts and understandings of the Covid-19 pandemic after having taken a semester-long course about the history of pandemics spanning from the black plague until the Spanish flu. We've discussed how we think the world could have handled this pandemic differently, the similarities and differences between this pandemic and previous pandemics, and how this pandemic affected our personal lives. -
05/06/2021
Liz Haynes, Oral History, 2021/04/21
Liz Haynes discusses her life pre-COVID and how she has been affected during COVID as a cancer survivor. She talks about her love of travel and hopefully future plans, politics (local and federal), and ends with positive outlook for the future. -
05/02/2021
Yang Rose Oral History, 2021/04/11
Rose Yang is a dental assistant and licensed realtor in Milwaukee, Wisconsin. Rose is interviewed by Kristopher Strebe in regard to her work, personal life, and role as a healthcare provider during the pandemic. Rose goes into depth about her jobs’ protocols against the pandemic and defends why she believes that pandemic will never be truly over for health officials working in healthcare. -
05/06/2021
Bekah Henn Orak History, 2021/05/06
C19OH -
2021-12-03
The New Variant
The new variant known as Omicron has started to appear in the U.S. as the WHO (World Health Organization) is more worried about its high number of mutations and labeled it as the "variant of concern." -
2021-11-29
St. Mary's University COVID 19 testing site(s)
This is one of many COVID 19 testing centers. We were fortunate to have this testing site made right here on St. Mary's University campus. -
2021-11-29
Are you sick and experiencing COVID 19 symptoms?
The public was or maybe still is a lot more fearful of contracting COVID 19. If you were sick at you were advised to stay at home and work due to fear of contracting the virus. This image identifies some ways to know if you or someone may be infected with COVID 19. -
2021-11-29
Needle stick accommodations made available to the public
Not everyone is a fan of hypodermic needles ( personally I am not). Healthcare has made considerable accommodations for those who are available for vaccinations by changing the size of the needle gauge; child and adult. By the healthcare industry developing new, different, and special accommodations for providing vaccinations via needle sticks are taking into consideration not everyone likes needles. For the most the public have a fear of needles. To now make the vaccinations a lot more welcoming for you as child /adult have options. There are now even needle-less "sticks" -
2021-11-26
Safety syringes (different sizes) adults and children
The attached photo is of retractable safety syringes (different sizes) adults and children -
2020-10-06
Bernd Geels Oral History 2020/10/06
C19OH -
2020-05-20
Debbie Woodall Oral History, 2020/04/29
Retired nurse, Debbie Woodall reflects on how she felt and handled the COVID 19 virus. She discusses her desire to return to work to help her former colleagues and the moment she realized she just couldn't. She also discusses other ways in which she aided the effort to stop the spread. -
2020-08-21
Michael Chow Oral History, 2020/08/21
C19OH -
2021-10-01
My Breakthrough COVID-19 Case
October 1, 2021, I woke up with a mild headache and a stuffy nose. I didn't think much of it—I had started drinking coffee again and needed a cup, and I’m mildly allergic to my own cats. My headache went away after I had my coffee, and my congestion ceased after I took my Claritin. After working remotely and basically not socializing for all of 2020 and up through August 2021, I was happy to be out and doing things again. In August, I started working and attending class in-person again, as well as spending time with friends. I still masked up and washed my hands according to guidelines, but it did seem like standards for that were slipping. I take public transit most days, and I’d seen a number of people who either weren’t wearing masks or not wearing them properly. But I still thought I was fairly safe since I followed COVID-19 recommendations, was fully vaccinated, and my campus has an extremely high vaccination rate (100% of students are vaccinated or have exemptions, and 98% of faculty/staff). So when I woke up experiencing what I thought were symptoms of seasonal allergies, I didn’t think anything of it. I went on a date that afternoon, and then out for drinks with friends later that night. I was very tired when I went home that night, but I chalked it up to how I’d over-committed myself in the initial euphoria of being able to participate in things again. Besides, I was sleeping better than I’d slept in years. The next day, my congestion was worse and I was coughing. I had an intermittent headache, but I assumed it was just a cold. One of my classmates that I sit next to had had one recently, and she’d tested negative for COVID, so I just assumed I’d picked it up from her. I remained congested and feeling gross that weekend, enough to call out from my shift on Sunday out of an abundance of caution, but I figured I’d be ready to be back by the time I had class and work again on Wednesday. But Monday afternoon I was working on some of my reading and realized I couldn’t smell the new (and very strong) candle in my living room. To test whether it was just the candle or whether it was me, I sniffed my perfume and finally even put peppermint essential oil right under my nose, and...nothing. Figuring that it was likely I had COVID at this point, I scheduled a test for the next day. I felt bad about having to get there—was it better to take an Uber or a train/bus? Which was safer for everyone involved? I ended up taking a Lyft, but I left the windows down and made sure I had cough drops so I wouldn’t cough. Once I arrived at the testing center (where I was the only patient), they got me through quickly and told me they’d be doing PCR testing and I could expect my results within a couple days. I called out of work for the week and let my professors know I likely had it. I woke up on Thursday morning to see my results had arrived, and I had tested positive. I called my school for contact tracing, and they notified the classmates I sit next to and my coworkers. I texted my friends I’d been out with Friday night and the person I went out with, and it was strange to feel almost ashamed. I had behaved responsibly, but I still felt as though I’d done something wrong in contracting COVID. And I was exhausted, tired of coughing, and just wanted my mom. I continued to improve, and I felt mostly better by the time my isolation period ended on the 11th. My sense of smell had started to come back, so I wasn’t as worried about a permanent loss there. I was a little concerned by the disregard for no-contact delivery I’d requested when getting food/groceries, but it had mostly been okay. My shifts at work had been given away, even though I was better and out of isolation by then. On the bright side, my cats were thrilled to have had me home that much, so at least it was a good experience for someone. Everyone I notified directly or via contact tracing tested negative, fortunately. When I started going back to things, I just wanted to scream on the train when I saw people not wearing masks or wearing them improperly. I still do, especially as the number of cases rises. -
2021-05-25
Breakthrough COVID-19 cases possible but rarity shows vaccine effectiveness
This graphic shows the rates of infection and hospitalization for breakthrough infections for COVID-19 among vaccinated people (as of May 2021) -
2021-03-26
Hagerstown Mass Vaccination Site
This photo shows a number of people at a mass vaccination event. -
2021-03-26
Participating in a Mass Vaccination Event
I was excited to get my vaccine as soon as the FDA approved the Pfizer vaccine. However, as a fairly healthy person who worked remotely, I was by no means going to be the first wave of vaccination. Truthfully, I thought I wouldn’t have a chance to get vaccinated until June or so, and I resigned myself to staying inside. In early March, I got an email from my school—the United Center was hosting a mass vaccination event, and they had more doses than the original target groups could use. I hurried to sign up. It filled quickly; I had a few friends tell me they were unable to get in. I was lucky, and I went to get my first dose near the end of March. Supposedly, Uber was offering free rides to/from the United Center (up to a certain amount, at least) for those seeking to get vaccinated. However, I kept getting error messages, so I made my way there by other methods. I panicked since I was almost late to my appointment for the first dose, but my worries faded when I arrived. The clinic volunteers kept the roped off lines going quickly and smoothly, though everyone was kept at least six feet apart. Once you’d been fully signed in—you showed your ID, your appointment voucher, got your temperature taken, and were issued an information packet—you waited to be sent to one of the FEMA people doing the vaccinating. I was called and got my first dose over with quickly and without any fuss, and then I was sent off to the tent where you waited to make sure you didn’t have any adverse side effects within the first 20 minutes. I was fine, so I went home with my vaccination card and instructions to return in 3 weeks. I returned 3 weeks later (in mid-April), and it went even more smoothly! They had worked out even more kinks, and everyone seemed relieved. While I’d been tired and a little sick a couple days after the first dose, the second one presented no problems. Later, I learned that a few of my friends were not only also part of the United Center mass vaccination event, but were there on the same days! I didn’t see them, but I’m not surprised given the efficiency of the process. Over the summer, the United Center’s vaccination program closed after it slowed significantly. So while I will be getting my booster shot soon, it won’t be as part of a mass vaccination endeavor. I’m a little reticent, simply because I don’t know what to expect from going to a pharmacy for it! -
2021-11-13
Anti-Vaxxers in the Family
I have a minimum of 2 resolute anti-vaxxers in my extended family. We try to avoid conflict but sometimes their ignorance is just too much for me to bear and I feel like I have to set the record straight. Here's a summary of what's going on in these screenshots from a FB post. 1. Great aunt posts a meme using the experience of the Polio vaccine to promote the COVID vaccine. (meme included) 2. Anti-vax aunt (orange) posts snarkily that in the case of the polio vaccine, it was only rolled out after 60 years of research. 3. I step in (as a historian of public health) and comment that she's mistaken, the polio vaccine went from lab to roll out in 25 years. While mRNA (on which the COVID vax is based) was first discovered in a lab 35 years ago so it stands to reason that the amount of time between lab and roll out is similar. 4. Meanwhile... anti-vax second cousin (purple- daughter of great aunt who made the original post and also resolutely anti-vax) tags anti-vax aunt (orange) and says "amen." as in... she lends her support 5. Anti-vax aunt (orange) responds to my initial rebuff in #3 and says "wrong. it took 35 years to discover it was a virus" (as if that, added to the 25 years of development constitutes 60 years of "research" 6. I step back in and repeat... polio vaccine research began in 1930, and it rolled out in the US in 1954. Surely she doesn't want to go back to the "good old days" when it took 30 years to discover whether something was a virus, really...?? 7. I was wrong. Anti-vax aunt (orangs) DOES want that. She says, "Yes, really" 8. pro-vax cousin (light blue-an oncology NP) comments "Wow. That's sad to think about" 9. Anti-vax aunt (orange): ? 10. pro-vax cousin (light blue): is we were not able to identify viruses like we can today. It's sad to think about all of the people that would die unnecessarily. This exchange went on but I just don't have it in me to continue with screenshots. Great aunt (original poster) chimes in and says she doesn't care what people's beliefs are but both of her daughters (one of them the anti-vaxxer in purple) families have COVID right now and she's in her 70s and was exposed to both and never caught it. She firmly believes it's because the vaccine works. Anti-vax aunt claimed she "didn't post a belief, she posted a fact" I said "no. you posted an incorrect fact that was skewed to make it look like the polio vaccine underwent 35 more years of research than it actually did and I corrected you." It's amazing to me that technology that has been in development for 35 years (mRNA) is seen with such suspicion because the virus it's being used with COVID-19 is new. So the assumption is that the vaccine is "untested" even though the technology behind it has a robust research history. I'm even more amazed by people who are anti-covid vaccine even though they had their full slew of childhood vaccines on schedule. I have two very close family members who refused to get vaccinated (different family members than the two distant family featured above) and they had all of their childhood vaccines. One of them even told me she fully expected that everyone who was vaccinated with the COVID vaccine will die in a few years or even "sprout dicks" for all she knows.... yes... It's imperative that we, as a society, figure out how to address misinformation and disinformation. Certainly, facts/statistics/"Research" are open to interpretation to a degree but much anti-vax info out there is politically motivated. It's not coming from scientists who spend their whole lives studying this stuff.... it's coming from PACs and anti-establishment groups who have beef with the US government and/or "Big Pharma" or Western medicine. -
2021-02-26
Illinois to open federal mass vaccination site at United Center
Parking lots of the United Center will soon host a new mass vaccination site for Illinoisans. Gov. JB Pritzker says the site will have the capacity to give 6,000 doses of vaccine per day. The home of the Chicago Bulls and Blackhawks will open as a vaccination site on March 10. But, construction is already underway. This will be one of the several community vaccination centers led by the Biden administration. Doses will come directly from the federal government instead of taking vaccine away from the allotment for the state and the city of Chicago. Leaders explained seniors will have exclusive access to appointments before the site officially opens. However, FEMA hasn’t set dates for those appointments at this time. Reporters asked how Pritzker could guarantee this facility would create easier access for those in need compared to wealthy Chicagoans. “In the city of Chicago, in Cook County, and across the state, we’ve all made and are continuing to make efforts to attract people of color to people who are most vulnerable to making those appointments, giving them access wherever we can. Having a site in a location like the United Center makes it more easily accessible,” Pritzker emphasized. Chicago Mayor Lori Lightfoot said rideshare service Uber will provide 20,000 free rides to help people get to the site. Information about scheduling appointments for vaccinations should become available in the coming days. “With this new site, we’ll now be able to take our vaccination success to a whole new level and bring to bear the historic and inclusive recovery that is soon to come,” Lightfoot explained. Getting Black and brown residents vaccinated Still, the state has a significant issue getting Black and Latinx Illinoisans vaccinated. U.S. Sen. Dick Durbin explained a recent study showed minority neighborhoods in Chicago had a vaccination rate of 5%. The majority-white areas of Chicago currently report 13% of the population vaccinated. Durbin says the United Center site should help. “The faster we can get people vaccinated, the more quickly we can escape the grip that this pandemic has had on our nation for so long, the less likely we’re gonna see mutations and variations which we have to fight in different ways,” Durbin added. The Springfield native said the federal government could provide more help with vaccine distribution bypassing the American Rescue Plan. President Joe Biden has asked Congress to approve the $1.9 trillion package with specific portions going to mass vaccination sites and $1,400 stimulus checks. Pritzker noted things are getting better in the long battle with COVID-19. “Someday not too far from now, we’ll be at the United Center not for a life-saving shot, but for a game-winning shot,” Pritzker said. -
2021-11-10
Children Ages 5-11 Now Eligible for Vaccine
The campaign to vaccinate elementary school age children in the U.S. is off to a strong start, health officials said Wednesday, but experts say there are signs that it will be difficult to sustain the initial momentum. About 900,000 kids aged 5 to 11 will have received their first dose of the COVID-19 vaccine in their first week of eligibility, the White House said, providing the first glimpse at the pace of the school-aged vaccination campaign. “We’re off to a very strong start,” said White House COVID-19 coordinator Jeff Zients, during a briefing with reporters. Final clearance for the shots was granted by federal regulators on Nov. 2, with the first doses to kids beginning in some locations the following day. The estimated increase in vaccinations in elementary school age children appears similar to a jump seen in May, when adolescents ages 12 to 15 became eligible for shots. Now nearly 20,000 pharmacies, clinics and physicians’ offices are offering the doses to younger kids, and the Biden administration estimates that by the end of Wednesday more than 900,000 of the kid doses will have been given. On top of that, about 700,000 first-shot appointments are scheduled for the coming days. About 28 million 5 to 11 year-olds are now eligible for the low-dose Pfizer vaccine. Kids who get their first of two shots by the end of next week will be fully vaccinated by Christmas. The administration is encouraging schools to host vaccine clinics on site to make it even easier for kids to get shots. The White House is also asking schools to share information from “trusted messengers” like doctors and public health officials to combat misinformation around the vaccines. A initial surge in demand for vaccinations was expected from parents who have been waiting for the chance to protect their younger kids, especially before the holidays. About 3% of newly eligible children in the U.S. got first shots in the first week, but the rate of vaccinations in varied widely around the country, as it has for adult vaccines. California Health and Human Services Secretary Dr. Mark Ghaly said Wednesday that more than 110,000 Californians ages 5 to 11 have received their first coronavirus shot — 9% of kids that age in the state. “We are starting to see this pick up and I’m really encouraged about what this means for our state,” Ghaly said. On the other ends of the spectrum, Idaho reported just 2,257 first shots, or 1.3% of the newly eligible kids there. In West Virginia’s Cabell County, high demand led local health officials to start setting up vaccination clinics in all the county’s public middle schools. A spokeswoman for the county health department said there were some lines for vaccines in the first few days after the doses were approved for kids ages 5 to 11, but that things have slowed since then. Some experts say that nationally, demand could also begin to recede soon. They note polling data suggests only a fraction of parents have planned to get their kids shots immediately, and they suspect the trend will play out like it did earlier this year when kids ages 12 to 15 were first able to get shots. In the first week after vaccines for that age group were authorized in May, the number of adolescents getting a first shot jumped by roughly 900,000, according to an American Academy of Pediatrics review of federal data. The next week, it rose even further, to 1.6 million. “There was an initial burst,” said Shannon Stokley of the Centers for Disease Control and Prevention. But then the number dropped steadily for months, interrupted only briefly in early August as the delta variant surged and parents prepared to send children back to school. Adolescent vaccinations have since flagged considerably, to just 32,000 getting their first shots last week. Only about half of adolescents ages 12 to 17 are fully vaccinated, compared to 70% of adults. It’s unlikely that vaccination rates in young kids will be as high as what’s seen in adults — or even in adolescents, some experts said, unless they are required for school. Part of the reason is that adults are far more likely than children to suffer serious illness or die from COVID-19, they noted. “Parents may have the perception it may not be as serious in young children or they don’t transmit it,” said Stokley, the acting deputy director of the CDC’s Immunization Services Division. But more than 2 million COVID cases have been reported in U.S. children ages 5 to 11 since the pandemic started, including 66 deaths over the past year, according to CDC data. “We’re going to have a lot of work to do to communicate to parents about why it’s important to get children vaccinated,” she said. Zients said the effort to vaccinate younger kids is still ramping up, with new clinics coming on line. Government officials expect the number of children who are vaccinated to keep rising in the days and weeks ahead, he said. “We are just getting started,” he said. Earlier this year the White House set — and missed — a July 4 goal to have at least certain percentage of U.S. adults vaccinated. Officials have not announced a similar target for kids. Dr. Lee Savio Beers, president of the American Academy of Pediatrics, called the new numbers reassuring and said the rollout appears to be going smoothly for the most part. She noted however that with a lower dose and different vials than for older kids, the rollout requires more steps and that some states have been slower in getting vaccine to providers. Initial data from some areas show Black children lagging behind whites in getting their first doses, which Beers said raises concerns. “It’s really important to make sure the vaccine is easily accessible in a wide variety of places,” Beers said. -
2021-09-16
The Importance of Context in Covid-19 Vaccine Safety
Vaccine safety is critical for the successful implementation of any vaccination program, especially during a pandemic. In February 1976, the Centers for Disease Control and Prevention confirmed a cluster of cases of severe influenza-like illness among Army recruits at Fort Dix, New Jersey.1 A swine influenza A strain that resembled the 1918 pandemic influenza strain was identified,2 and a vaccination program was subsequently initiated for the entire U.S. population. After more than 40 million persons were vaccinated, a small excess risk of Guillain–Barré syndrome was noted, with an attributable risk of approximately 1 case per 100,000 doses administered. Given these concerns and because the pandemic did not materialize, the vaccination program was halted in December 1976 so that the issue could be explored further. This experience shed light on the need for real-time vaccine safety surveillance and the importance of context in decision making during a pandemic. In a study now reported in the Journal by Barda et al., the investigators simultaneously evaluated the risk of adverse events among persons (≥16 years of age) who had received the BNT162b2 vaccine (Pfizer–BioNTech) and the risk of the same events after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.3 The authors used data from the largest integrated payer–provider health care organization in Israel, in conjunction with data on SARS-CoV-2 polymerase-chain-reaction tests and data on coronavirus disease 2019 (Covid-19) vaccine administration from the Israeli Ministry of Health. This use of multiple data sets highlights the importance of investment in digital capabilities and meaningful integration across systems in order to provide real-time answers to key public health questions. The design of rigorous postauthorization vaccine safety studies during the Covid-19 pandemic has been a challenge because the pandemic itself has caused changes in health care utilization, the rollout of Covid-19 vaccines has occurred in phases because of initial supply limitations, and there have been disparities in access to vaccines. Barda et al. broadly addressed many of these challenges by emulating a trial that matched eligible vaccinees to unvaccinated controls according to sociodemographic characteristics, the number of preexisting chronic health conditions, previous health care utilization, and pregnancy status. In the vaccination analysis, the study included 42 days of follow-up (i.e., 21 days after the first dose and 21 days after the second dose). This analysis accounted for seasonal and secular trends by matching on the day of vaccination, rather than relying on historical risk estimates that may not have been comparable in the pandemic setting. In the SARS-CoV-2 analysis, a similar approach was used to match persons with a newly diagnosed infection to uninfected persons. Although the risk estimates in the vaccination and the SARS-CoV-2 analyses were not directly comparable because of differences in the populations (i.e., events were evaluated per 100,000 vaccinated persons and per 100,000 infected persons, respectively), these risks were placed in context. The most salient example is myocarditis, which has received much attention recently given the preponderance of reported cases after vaccination among adolescents and young adults and the incidence of myocarditis observed after SARS-CoV-2 infection.4-6 In the population-based cohort in the study conducted by Barda and colleagues, the risk ratios for myocarditis were 3.24 (95% confidence interval [CI], 1.55 to 12.44) after vaccination and 18.28 (95% CI, 3.95 to 25.12) after SARS-CoV-2 infection, with risk differences of 2.7 events per 100,000 persons (95% CI, 1.0 to 4.6) and 11.0 events per 100,000 persons (95% CI, 5.6 to 15.8), respectively. What is even more compelling about these data is the substantial protective effect of vaccines with respect to adverse events such as acute kidney injury, intracranial hemorrhage, and anemia, probably because infection was prevented. Furthermore, the persons with SARS-CoV-2 infection appeared to be at substantially higher risk for arrhythmia, myocardial infarction, deep-vein thrombosis, pulmonary embolism, pericarditis, intracerebral hemorrhage, and thrombocytopenia than those who received the BNT162b2 vaccine. National discussions about benefit–risk balance often focus on the benefits of preventing symptomatic disease, hospitalization, or death due to Covid-19 and the risks of serious adverse events after vaccination.7,8 As specific adverse events such as myocarditis are highlighted, however, the lack of corresponding specificity about benefits can hamper efforts to communicate effectively with patients. Messenger RNA (mRNA) vaccines may be associated with myocarditis, but they can also prevent cases of myocarditis, acute kidney injury, arrhythmia, and thromboembolic disease. The key to comparing these risks depends on the risk of SARS-CoV-2 infection to an individual person, and that risk can vary according to place and over time. Given the current state of the global pandemic, however, the risk of exposure to SARS-CoV-2 appears to be inevitable. One major limitation of this study is the lack of risk estimates according to age group and sex. For example, thrombosis with thrombocytopenia syndrome occurs predominantly in young adult women who have received adenoviral vector vaccines against SARS-CoV-2, whereas myocarditis predominantly occurs in male teens and young men who have received mRNA vaccines.5,9,10 Age- and sex-stratified comparisons that reflect local epidemiologic factors might support public understanding of different approaches to vaccine use in different countries, such as Israel, the United Kingdom, and the United States. Other limitations of the study include the paucity of data regarding younger teens and children, the conservative assumption that vaccines have no effect on transmission, and the absence of medical record review to validate computable phenotypes (i.e., algorithms used to identify a cohort on the basis of patient records). As new knowledge of the safety and benefits of vaccines continues to evolve, studies like this one may help to support decision making about the use of Covid-19 vaccines. The benefit–risk balance should be reassessed, refined, and communicated as the disease burden changes, new variants and safety signals emerge, and vaccine effectiveness begins to wane. Context matters, which means that we as a country need to be ready for continual learning and change. -
2021-11-11
What We Know So Far About Waning Vaccine Effectiveness
As tens of millions who are eligible in the United States consider signing up for a Covid-19 booster shot, a growing body of early global research shows that the vaccines authorized in the United States remain highly protective against the disease’s worst outcomes over time, with some exceptions among older people and those with weakened immune systems. But while the vaccines’ effectiveness against severe disease and hospitalization has mostly held steady, even through the summer surge of the highly transmissible Delta variant, a number of published studies show that their protection against infection, with or without symptoms, has fallen. Public health experts say this decline does not mean that the vaccines are not working. In fact, many studies show that the vaccines remain more than 50 percent effective at preventing infection, the level that all Covid vaccines had to meet or exceed to be authorized by the Food and Drug Administration back in 2020. But the significance of these declines in effectiveness — and whether they suggest all adults should be eligible for a booster shot — is still up for debate. -
2021-04-06
Biden will offer a virus update as the pace of vaccination accelerates
President Biden will promote his administration’s success in accelerating the pace of coronavirus vaccinations during two appearances on Tuesday, as officials in nearly every state say they will make shots available to all adults by his target of April 19. Three months into his presidency, Mr. Biden confronts an escalating migrant surge at the border with Mexico and has embarked on a grind-it-out effort to ram through a $2.3 trillion infrastructure bill. But the virus remains his primary focus. And he wants the country to know that — so he is offering multiple updates each week, along with helpful visual cues, like standing next to a giant Easter bunny wearing a mask. On Tuesday afternoon, Mr. Biden will travel to Alexandria, Va., to tour a vaccination site at the Virginia Theological Seminary. Later, at the White House, he will deliver remarks emphasizing recent successes, including the milestone of delivering four million vaccinations in one day over the weekend. More than three million doses are now being given on average each day, compared with well under one million when Mr. Biden took office in January, according to the Centers for Disease Control and Prevention. Every state has now given at least one dose to a quarter or more of its population. About 62.4 million people — 19 percent of Americans — have been fully vaccinated. On Monday, Gov. Larry Hogan of Maryland announced that all Maryland residents 16 or older would be eligible from Tuesday for a shot at the state’s mass vaccination sites, and starting April 19 at any vaccine provider in the state. Also on Monday, Gov. Philip D. Murphy of New Jersey and Mayor Muriel Bowser of Washington, D.C., said residents 16 or older would be eligible on April 19. Gov. Kate Brown of Oregon announced Tuesday that all Oregonians over the age of 16 were eligible to receive a vaccine. The state had been limiting the doses to those with underlying conditions and frontline workers. That leaves one state, Hawaii, keeping to Mr. Biden’s original deadline of May 1. In Hawaii, 34 percent of residents have received at least one dose. Alabama has vaccinated the lowest proportion of its residents, at 25 percent. Along with dangerous coronavirus variants that were identified in Britain, South Africa and Brazil, new mutations have continued to pop up in the United States, from California to New York to Oregon. The shots will eventually win, scientists say, but because each infection gives the coronavirus a chance to evolve further, vaccinations must proceed as quickly as possible. For now, however, cases are rising sharply in parts of the country, with some states offering a stark reminder that the pandemic is far from over. Yet again, governors across the country have lifted precautions like mask mandates and capacity limits on businesses. -
2020-09-14
Pfizer and BioNTech announce plan to expand Covid-19 vaccine trial
Pfizer and BioNTech are moving to enlarge the Phase 3 trial of their Covid-19 vaccine by 50%, which could allow the companies to collect more safety and efficacy data and to increase the diversity of the study’s participants. The companies said in a press release that they would increase the size of the study to 44,000 participants, up from an initial recruitment goal of 30,000 individuals. The U.S. Food and Drug Administration will have to approve the change before it goes into effect. “The companies continue to expect that a conclusive readout on efficacy is likely by the end of October,” the press release said. The Pfizer and BioNTech study is likely to be among the first in the U.S. to report efficacy data from a Phase 3 trial. Related: AstraZeneca resumes Covid-19 vaccine trials in the U.K. Expanding the trial will likely make it easier for the company to demonstrate whether the vaccine is effective against SARS-CoV-2, the virus that causes Covid-19. The companies also said that the change will allow the study to include a more diverse population. The companies said the study will now include adolescents as young as 16, people with stable HIV, and those with hepatitis C or hepatitis B. The companies said that the trial is expected to reach its initial target of 30,000 patients next week. Moderna, which started its trial on the same day as Pfizer, said on Sept. 4 that it is working to increase the diversity of trial participants in its study, “even if those efforts impact the speed of enrollment.” Related: Covid-19 Drugs and Vaccines Tracker The Pfizer/BioNTech study could finish sooner than Moderna’s, even though the two began on the same day, for other reasons, as well. Both vaccines require a second shot; Pfizer’s is given after three weeks, while Moderna’s is given after four. The Pfizer trial also starts to count cases of Covid-19 sooner after participants receive their shots than the Moderna study. But the Pfizer/BioNTech vaccine could also prove to be one of the most difficult of the experimental vaccines to distribute, should they prove effective. The vaccine must be kept at a temperature of -70 degrees Celsius. There has been political pressure to move a vaccine quickly, with President Trump saying that one could be available before election day. Last week, several drugmakers, including Pfizer, issued a pledge not to move a vaccine forward sooner than was justified by the results of their clinical trials. -
2020-07-14
Moderna Phase 1 results show coronavirus vaccine safe, induces immune response
Moderna Inc’s experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday. Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19, the team reported in the New England Journal of Medicine. No study volunteers experienced a serious side effect, but more than half reported mild or moderate reactions such as fatigue, headache, chills, muscle aches or pain at the injection site. These were more likely to occur after the second dose and in people who got the highest dose. Experts say a vaccine is needed to put an end to the coronavirus pandemic that has sickened millions and caused nearly 575,000 deaths worldwide. Moderna was the first to start human testing of a vaccine for the novel coronavirus on March 16, 66 days after the genetic sequence of the virus was released. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, whose researchers developed Moderna’s vaccine candidate, called the results “good news,” noting that the study found no serious adverse events and the vaccine produced “reasonably high” levels of virus-killing or neutralizing antibodies. “If your vaccine can induce a response comparable with natural infection, that’s a winner,” Fauci said in a telephone interview. “That’s why we’re very pleased by the results.” Moderna shares jumped more than 15% in after-hours trading on Tuesday. The U.S. government is supporting Moderna’s vaccine with nearly half a billion dollars and has chosen it as one of the first to enter large-scale human trials. A successful vaccine could be a turning point for Cambridge, Massachusetts-based Moderna, which has never had a licensed product. Moderna’s shot, mRNA-1273, uses ribonucleic acid (RNA) - a chemical messenger that contains instructions for making proteins. When injected into people, the vaccine instructs cells to make proteins that mimic the outer surface of the coronavirus, which the body recognizes as a foreign invader, and mounts an immune response against. The results released Tuesday involved three doses of the vaccine, tested in groups of 15 volunteers aged 18-55 who got two shots, 28 days apart. The groups tested 25, 100 or 250 micrograms of the vaccine. Adverse events after the second dose occurred in seven of the 13 volunteers who got the 25-microgram dose, all 15 participants who received the 100 microgram dose and all 14 who got the 250 microgram dose. In the highest-dose group, three patients had severe reactions such as fever, chills, headache or nausea. One of these had a fever of 103.28 Fahrenheit (39.6 C). “We didn’t see any events that are characterized as serious adverse events,” said lead author Dr Lisa Jackson of Kaiser Permanente Washington Health Research Institute in Seattle, referring to reactions that require hospitalization or result in death. In June, Moderna said it selected the 100-microgram dose for its late-stage study to minimize adverse reactions. At that dose, Moderna said the company is on track to deliver about 500 million doses per year, and possibly up to 1 billion doses per year, starting in 2021, from the company’s internal U.S. manufacturing site and strategic collaboration with Swiss drugmaker Lonza. “It’s a good first step,” said Dr William Schaffner, a vaccine expert at Vanderbilt University Medical Center who was not involved in the study. “There’s nothing here that would inhibit one from going ahead to the Phase 2/Phase 3 trials,” he said. In April, Moderna expanded the Phase 1 trial to include adults over 55, who are more at risk of serious disease, with the aim of enrolling 120 volunteers. Moderna said it will follow study volunteers for a year to look for side effects and check how long immunity lasts. Moderna started its phase 2 trial in May and expects to start a phase 3 trial on July 27. Phase 1 trials aim to ensure a treatment is safe and help determine an effective dose. Phase 2 trials test a treatment in a larger group and get an early read on effectiveness. Phase 3 trials are conducted in a large group of individuals to confirm efficacy and identify rare side effects. Moderna’s Phase 3 trial will be conducted in 30,000 volunteers. -
2021-09-09
HIST30060 Father's Day
This is a card my siblings and I wrote for our dad. In September my father was sent into emergency as he had to have a quadruple bypass. It was rather scary as no one could visit him whilst he was recovering. We are extremely lucky that his surgery got pushed forward by his cardiologist as now our public healthcare system is now struggling and surgeries like what my dad had are being postponed. His surgery was even postponed as another cardiology ward in a nearby hospital had a covid outbreak so the nurses and doctors at his hospital had to work over there. My dad came home a couple days after Father’s Day (it was the first Father’s Day we didn’t spend with him in our lives) and is now feeling so much better. The first thing he told me when he came home was that he “never wants to get covid” because he was on a ventilator, and it was “the worst part” of the whole experience. I genuinely thought he was on the ventilator for a day or multiple days as he didn’t stop complaining about how bad it was - turns out he was only conscious with the ventilator in him for just under an hour. -
2020-07-28
Preparing Your Child for a COVID-19 Test
A blog post from Banner Health about helping children take a Covid-19 test -
2020-07-21
COVID-19: How to Help Your Child Navigate This New Normal
A blog post from Banner Health about helping children during Covid-19. -
2020-07-15
Tips for Managing Anxiety in the Midst of COVID-19
A blog post from Banner Health about managing stress and anxiety during Covid-19. -
2021-03-05
First State Mass Vaccination Clinic
A screenshot of when my college announced that our basketball arena would house the first mass vaccination center in our state. I sent this to my family because I thought it was so cold my college got this opportunity. Most of my family got vaccinated here and it was so well run and easy! -
2021-07-08
Has COVID-19 Created Conflict in Your Relationship?
A blog post from Banner Health about relationships with partners and spouses during Covid-19. -
2020-07-09
Navigating Postpartum Depression During COVID-19
A blog post from Banner Health about post-partum depression during Covid-19. -
2021-10-21
HIST30060 Melbourne Convention Centre
This is a picture of the outside of the Melbourne Convention Centre while crossing the Yarra, where I received my second dose of AstraZeneca COVID vaccine on 12:30pm October 21st, 2021. When I had received the first dose on August 27th, a line had wrapped around the building of at least a hundred people walking in to receive Pfizer. However, by this date, you can see by the photo that there were far fewer people waiting to receive their second dose. Even though I was half an hour early to my appointment, there were so few people that the staff waved me through without any problems. The whole time I was inside the convention centre, I probably saw only twenty people, excluding staff. HIST30060. -
2020-03-07
HIST30060 Environmental impact of the pandemic
This photo shows a large amount of waste in the form of face masks that were found washed up on a beach in Hong Kong. While the pandemic has been argued to have brought some environmental benefits, namely from the reduced pollution that comes with fewer cars on the road, this photo shows that our efforts to protect ourselves are harming our oceans. Discarding of our disposable face masks responsibly is something we should all keep in mind in the course of the pandemic. -
2021-10-01
Vaccination Badge (HIST30060)
(HIST30060) This is a photo of the badge I received after getting my second dose of the Pfizer vaccine. I currently work as a medical receptionist at a GP clinic that has been running vaccination sessions – this is where I was vaccinated and received the badge. The badge reads: ‘Arm yourself against COVID-19…I got vaccinated’. The badge is colourful and eye-catching, and the pun is…punchy. I think it acutely captures the typography, tone and gist of the recent government advertisements urging people to get the vaccine. -
2021-10-14T19:40
The Clonky Helmet
I personally worked as a COVID 19 screener for South Texas Veterans Affairs. During that time we as COVID screeners were required to wear face shields and masks on our face for more than eight hours a day. After reading the article I posted from the CDC -- it now does not seem like it was a requirement at all for health workers to wear the face shields. I preferred to wear the ones that were much lighter. They were also face shields, but they were not in a shape of a helmet, they were lighter, and easier to handle as we screeners went from one job station to another. During the pandemic, while employed as a COVID 19 screener-- if we were caught without wearing the helmet (face shield) our jobs were threatened. We were only allowed to take the face shields off intermittently, for example, while at lunch. -
2021-03-14
Paradigm Shifts
The COVID-19 pandemic has brought about many paradigm shifts; everyone I know has undergone a lot of change in themselves, their beliefs, and in how they view and interact with the world. There is a lot of grief these days but there are changes worth being happy about. -
2021-10-15
Tense and Tempestuous Tones
In the year 2020, I was a medical assistant working for a cancer surgery clinic. The pandemic posed huge challenges for people working in healthcare and created new staggering standards for cleanliness and infection control. With limited personal protective equipment and cleaning supplies, it made everyday clinic operations very challenging. With cancer patients, most of whom were undergoing treatments that lowered their immune system, and many of whom had just had surgery which can increase risk of infection, medical staff took COVID safety precautions very seriously. Dealing with people battling illness can be challenging under normal circumstances because they are often feeling emotional and scared, but during COVID, tensions were running even higher. I will never forget patients using condescending, edgy, and outright angry tones with me when I would call for a COVID symptom screening prior to their appointment, inform them that they had to wear a mask at all times while in the clinic, or that they were unable to bring a family member to the exam room during a follow-up appointment with a doctor. Over the phone and in person, many patients used tense and tempestuous tones to take out their anger over a situation none of us had any control over. Often, there were political connotations to any discussion of clinic COVID policy, which was unusual in a conversation about infection control. Many patients would protest getting their temperature taken or question the accuracy of their oximetry reading (a started part of vitals even before the pandemic). It was always a relief to have a patient who took a dignified breath and calmly understood that the rules were in place for everyone's safety and were an inconvenience to all involved. There were several days where I would go off to an empty exam room during my lunch break and cry. Tension during the first year of the COVID pandemic was audible.